drugset / Trial / NCT02317744

Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo

NCT02317744

Completed 22 enrolled Yale University
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will test the effectiveness of the combination of Naltrexone and Bupropion relative to placebo for reducing binge eating in persons with obesity and binge eating disorder.

Timeline

Start
2014-12
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg
Subject Naltrexone Small molecule 50 mg

Indications